First Header Logo Second Header Logo

Michael Chan

Concepts (363)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiosurgery
65
2020
355
16.610
Why?
Brain Neoplasms
78
2020
636
16.230
Why?
Meningioma
11
2020
59
3.290
Why?
Glioblastoma
13
2020
158
3.180
Why?
Cranial Irradiation
14
2020
94
3.060
Why?
Salvage Therapy
17
2020
135
2.760
Why?
Middle Aged
84
2020
11843
2.460
Why?
Neoplasm Recurrence, Local
16
2020
372
2.420
Why?
Trigeminal Neuralgia
8
2019
33
2.420
Why?
Retrospective Studies
51
2020
3612
2.340
Why?
Treatment Outcome
45
2020
3410
2.260
Why?
Glioma
12
2020
137
2.130
Why?
Aged
65
2020
10257
2.110
Why?
Lung Neoplasms
15
2020
422
2.060
Why?
Female
94
2020
19954
2.000
Why?
Meningeal Neoplasms
8
2020
49
1.980
Why?
Humans
124
2020
32284
1.960
Why?
Radiotherapy
7
2019
92
1.940
Why?
Male
85
2020
19434
1.890
Why?
Adult
58
2020
9263
1.680
Why?
Aged, 80 and over
35
2020
3896
1.660
Why?
Melanoma
9
2019
166
1.480
Why?
Follow-Up Studies
28
2020
2238
1.450
Why?
Multiple Sclerosis
3
2019
61
1.250
Why?
Prognosis
14
2020
1529
1.230
Why?
Neoplasms
6
2020
763
1.170
Why?
Nomograms
4
2017
35
1.050
Why?
Survival Analysis
13
2020
478
0.960
Why?
Breast Neoplasms
11
2019
767
0.960
Why?
Survival Rate
12
2020
892
0.940
Why?
Magnetic Resonance Imaging
15
2020
1211
0.870
Why?
Intracranial Arteriovenous Malformations
4
2019
19
0.870
Why?
Antineoplastic Agents, Alkylating
4
2018
44
0.840
Why?
Adenocarcinoma
4
2019
298
0.830
Why?
Radiotherapy Dosage
13
2017
106
0.830
Why?
Cognition Disorders
4
2015
349
0.830
Why?
Carcinoma, Non-Small-Cell Lung
6
2019
108
0.820
Why?
Neoplasm Metastasis
7
2020
222
0.790
Why?
Postoperative Complications
6
2019
818
0.780
Why?
Genomics
3
2018
89
0.750
Why?
Radiation Injuries
7
2016
85
0.740
Why?
Disease Progression
7
2020
590
0.730
Why?
Young Adult
18
2020
2652
0.730
Why?
Treatment Failure
10
2020
164
0.670
Why?
Disease-Free Survival
11
2020
322
0.650
Why?
Radiotherapy, Adjuvant
3
2017
83
0.630
Why?
Astrocytoma
2
2018
28
0.630
Why?
Carcinoma
1
2020
92
0.600
Why?
Combined Modality Therapy
9
2018
550
0.570
Why?
Pineal Gland
1
2018
2
0.570
Why?
Brain
8
2019
966
0.560
Why?
Costs and Cost Analysis
1
2018
106
0.550
Why?
Adolescent
11
2020
3521
0.540
Why?
Small Cell Lung Carcinoma
4
2020
17
0.520
Why?
Hypoglycemic Agents
1
2018
186
0.510
Why?
Nervous System Neoplasms
1
2017
8
0.500
Why?
Medicare
1
2018
218
0.500
Why?
Gastrointestinal Neoplasms
1
2017
35
0.490
Why?
Cerebellar Neoplasms
2
2019
11
0.470
Why?
Brain Edema
2
2014
16
0.450
Why?
Radiotherapy Planning, Computer-Assisted
2
2012
34
0.450
Why?
Ganglioglioma
1
2015
6
0.440
Why?
Central Nervous System Diseases
1
2015
17
0.440
Why?
Benzhydryl Compounds
1
2015
23
0.440
Why?
Neurofibromatosis 2
1
2015
5
0.440
Why?
Fatigue
1
2015
80
0.430
Why?
Choroid Neoplasms
2
2011
4
0.420
Why?
Meningeal Carcinomatosis
1
2014
7
0.420
Why?
Incidence
4
2020
1244
0.420
Why?
Proportional Hazards Models
5
2019
773
0.410
Why?
Pain Measurement
3
2014
340
0.410
Why?
Brain Stem Neoplasms
1
2014
4
0.410
Why?
Tomography, X-Ray Computed
4
2014
906
0.410
Why?
Carcinoma, Small Cell
1
2013
21
0.400
Why?
Smoking
1
2017
505
0.390
Why?
Carcinoma, Squamous Cell
2
2019
156
0.390
Why?
Visual Acuity
3
2014
76
0.380
Why?
Risk Factors
7
2019
3938
0.380
Why?
Radiotherapy, Computer-Assisted
1
2012
3
0.370
Why?
Carcinoma, Basal Cell
1
2012
27
0.370
Why?
Randomized Controlled Trials as Topic
2
2016
548
0.360
Why?
Ependymoma
1
2012
4
0.350
Why?
Surgery, Computer-Assisted
1
2012
65
0.350
Why?
Vision Disorders
1
2011
23
0.340
Why?
Child
7
2020
2446
0.340
Why?
Antineoplastic Agents
6
2018
595
0.340
Why?
Neoplastic Stem Cells
4
2020
93
0.340
Why?
Time Factors
6
2017
2196
0.340
Why?
Collagen Diseases
1
2011
5
0.340
Why?
Tumor Burden
5
2014
62
0.330
Why?
Cell Line, Tumor
12
2020
726
0.330
Why?
Radiation Dosage
3
2020
90
0.330
Why?
Medulloblastoma
1
2010
8
0.320
Why?
Vascular Diseases
1
2011
66
0.320
Why?
Cohort Studies
5
2019
1840
0.320
Why?
Prospective Studies
8
2019
2320
0.320
Why?
Brachytherapy
1
2010
29
0.320
Why?
Dose-Response Relationship, Radiation
3
2015
82
0.320
Why?
Radiation Oncology
1
2010
14
0.310
Why?
Lymphoma
1
2010
37
0.310
Why?
Catheter Ablation
1
2010
113
0.290
Why?
Facial Pain
3
2014
21
0.290
Why?
Radiotherapy, Intensity-Modulated
3
2015
35
0.290
Why?
Microglia
2
2020
67
0.280
Why?
Image Processing, Computer-Assisted
4
2020
232
0.280
Why?
Proto-Oncogene Proteins c-met
2
2018
19
0.260
Why?
Databases, Factual
2
2020
368
0.260
Why?
Neoplasm Staging
3
2015
458
0.250
Why?
Radiotherapy, Conformal
2
2018
18
0.250
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
442
0.250
Why?
Signal Transduction
4
2020
716
0.250
Why?
Central Nervous System Neoplasms
3
2014
30
0.250
Why?
Multivariate Analysis
4
2014
650
0.220
Why?
Mice
10
2020
2544
0.220
Why?
Brain Death
2
2017
23
0.220
Why?
Lymphatic Metastasis
3
2019
169
0.210
Why?
Clinical Trials as Topic
2
2019
312
0.200
Why?
Child, Preschool
3
2020
1248
0.200
Why?
DNA Methylation
2
2015
144
0.200
Why?
Cause of Death
2
2015
236
0.200
Why?
Quality of Life
3
2019
971
0.200
Why?
Carcinoma, Renal Cell
2
2017
113
0.190
Why?
Animals
14
2020
8165
0.190
Why?
Gene Expression Regulation, Neoplastic
6
2019
257
0.180
Why?
Kidney Neoplasms
2
2017
200
0.180
Why?
Neuropsychological Tests
4
2019
327
0.180
Why?
Recurrence
4
2019
287
0.180
Why?
Electromagnetic Fields
2
2019
26
0.170
Why?
Antigens, Neoplasm
2
2019
38
0.170
Why?
Receptor, erbB-2
3
2020
63
0.170
Why?
Janus Kinase 2
1
2020
6
0.160
Why?
Mice, Nude
5
2020
285
0.160
Why?
Analysis of Variance
3
2017
470
0.160
Why?
Immunity, Innate
1
2020
81
0.150
Why?
Plasma Cells
1
2019
12
0.150
Why?
Syndecan-1
1
2019
20
0.150
Why?
Risk
1
2020
305
0.150
Why?
Magnetic Field Therapy
1
2019
15
0.150
Why?
Cystatin A
1
2019
7
0.150
Why?
Oligodendroglioma
1
2019
2
0.150
Why?
Hemangioblastoma
1
2019
4
0.140
Why?
Interleukin-23 Subunit p19
1
2019
10
0.140
Why?
Calcium Channels, T-Type
1
2019
28
0.140
Why?
von Hippel-Lindau Disease
1
2019
5
0.140
Why?
Carcinoma, Bronchogenic
1
2018
6
0.140
Why?
RNA, Neoplasm
1
2018
18
0.140
Why?
Maximum Tolerated Dose
1
2018
62
0.140
Why?
Retreatment
2
2016
42
0.140
Why?
Biopsy, Fine-Needle
1
2018
62
0.140
Why?
Postoperative Period
1
2018
95
0.140
Why?
Protons
1
2018
22
0.140
Why?
Transcription Factors
1
2019
184
0.140
Why?
Nicotine
1
2020
164
0.140
Why?
Microfilament Proteins
1
2018
37
0.140
Why?
Magnetic Resonance Spectroscopy
1
2018
93
0.140
Why?
Neovascularization, Pathologic
3
2016
75
0.130
Why?
Disease Management
1
2019
129
0.130
Why?
Exosomes
1
2018
43
0.130
Why?
Dacarbazine
2
2016
31
0.130
Why?
Glomus Jugulare Tumor
1
2017
4
0.130
Why?
Calcium
1
2019
337
0.130
Why?
Hearing Tests
1
2017
12
0.130
Why?
Bone Neoplasms
1
2018
104
0.130
Why?
Double-Blind Method
2
2015
566
0.130
Why?
Diffusion Tensor Imaging
1
2016
24
0.120
Why?
Confidence Intervals
1
2017
141
0.120
Why?
Interferon-Stimulated Gene Factor 3, gamma Subunit
1
2016
2
0.120
Why?
Sulfides
1
2016
27
0.120
Why?
Caprylates
1
2016
27
0.120
Why?
MicroRNAs
1
2018
181
0.120
Why?
Diffusion Magnetic Resonance Imaging
1
2016
49
0.120
Why?
Cell Proliferation
4
2019
599
0.120
Why?
Survivors
2
2018
174
0.120
Why?
Neoplasm Invasiveness
1
2016
180
0.110
Why?
Urinary Bladder Neoplasms
1
2018
189
0.110
Why?
DNA Modification Methylases
1
2015
11
0.110
Why?
DNA Repair Enzymes
1
2015
14
0.110
Why?
Radiation-Sensitizing Agents
2
2017
17
0.110
Why?
Hypesthesia
2
2015
9
0.110
Why?
Matrix Metalloproteinase 1
1
2015
5
0.110
Why?
Sarcoma
1
2016
82
0.110
Why?
Tumor Suppressor Proteins
1
2015
64
0.110
Why?
Indans
1
2015
31
0.110
Why?
Carmustine
1
2015
10
0.110
Why?
Cyclooxygenase 2
1
2015
51
0.110
Why?
Stereotaxic Techniques
1
2014
23
0.110
Why?
Lung
1
2016
264
0.110
Why?
Prevalence
2
2014
960
0.100
Why?
Neurosurgical Procedures
1
2015
93
0.100
Why?
Piperidines
1
2015
137
0.100
Why?
Brain Stem
1
2014
22
0.100
Why?
Uveal Neoplasms
1
2014
25
0.100
Why?
PPAR alpha
1
2014
24
0.100
Why?
Taste
1
2013
17
0.100
Why?
Influenza Vaccines
1
2014
82
0.100
Why?
Fatty Acids, Unsaturated
1
2013
43
0.090
Why?
Eye Proteins
1
2013
36
0.090
Why?
Smell
1
2013
45
0.090
Why?
Cost-Benefit Analysis
1
2013
191
0.090
Why?
Macular Degeneration
1
2013
25
0.090
Why?
Receptors, Progesterone
1
2012
50
0.090
Why?
Neoplasms, Radiation-Induced
1
2012
14
0.090
Why?
Ramipril
1
2012
3
0.090
Why?
Regression Analysis
1
2013
273
0.090
Why?
Liver Neoplasms
1
2014
164
0.090
Why?
Receptors, Estrogen
1
2012
104
0.090
Why?
Neurilemmoma
1
2012
17
0.090
Why?
Radiation Injuries, Experimental
1
2012
37
0.090
Why?
Nitrogen Mustard Compounds
1
2012
4
0.090
Why?
Pain, Postoperative
1
2014
198
0.090
Why?
Lymphoma, Non-Hodgkin
1
2012
28
0.090
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2012
133
0.090
Why?
Membrane Proteins
1
2013
243
0.090
Why?
Magnetic Resonance Angiography
1
2011
72
0.090
Why?
Age Factors
2
2013
1179
0.090
Why?
Facial Paralysis
1
2011
6
0.090
Why?
Hydrocephalus
1
2011
11
0.090
Why?
Arthritis, Rheumatoid
1
2011
37
0.080
Why?
Cerebral Cortex
1
2012
144
0.080
Why?
Trigeminal Nerve
1
2010
5
0.080
Why?
Craniopharyngioma
1
2010
7
0.080
Why?
Pituitary Neoplasms
1
2010
15
0.080
Why?
Glial Fibrillary Acidic Protein
1
2010
43
0.080
Why?
Microtubule-Associated Proteins
1
2010
32
0.080
Why?
Lupus Erythematosus, Systemic
1
2011
149
0.080
Why?
Cell Membrane
1
2010
109
0.080
Why?
United States
1
2018
4079
0.080
Why?
Sarcoma, Myeloid
1
2009
4
0.080
Why?
North Carolina
1
2013
1299
0.080
Why?
Cognition
1
2014
548
0.080
Why?
Heart Neoplasms
1
2009
19
0.080
Why?
Xenograft Model Antitumor Assays
2
2020
114
0.070
Why?
Mice, Inbred BALB C
2
2020
199
0.070
Why?
Endothelial Cells
1
2010
190
0.070
Why?
Leukemia, Myeloid, Acute
1
2009
211
0.070
Why?
Microscopy, Fluorescence, Multiphoton
1
2007
2
0.060
Why?
Radiodermatitis
1
2006
6
0.060
Why?
Green Fluorescent Proteins
1
2007
70
0.060
Why?
Rhabdoid Tumor
1
2006
2
0.060
Why?
Cell Separation
1
2007
86
0.060
Why?
Deoxycytidine
1
2006
57
0.060
Why?
Antimetabolites, Antineoplastic
1
2006
48
0.060
Why?
Flow Cytometry
1
2007
184
0.060
Why?
Neoplasm Transplantation
2
2018
73
0.060
Why?
Teratoma
1
2006
9
0.060
Why?
Transplantation, Heterologous
2
2018
109
0.060
Why?
Gene Expression Profiling
2
2019
325
0.060
Why?
Immunohistochemistry
2
2019
544
0.050
Why?
Blotting, Western
2
2015
297
0.050
Why?
Pilot Projects
2
2014
554
0.050
Why?
Intracranial Hemorrhages
2
2013
34
0.050
Why?
Palliative Care
2
2017
50
0.050
Why?
Cerebral Angiography
2
2012
60
0.040
Why?
Amygdala
2
1999
60
0.040
Why?
Body Weight
2
2014
323
0.040
Why?
Anilides
1
2020
12
0.040
Why?
Biphenyl Compounds
1
2020
21
0.040
Why?
Chemokine CCL20
1
2020
6
0.040
Why?
STAT3 Transcription Factor
1
2020
22
0.040
Why?
Alternative Splicing
1
2020
32
0.040
Why?
Receptors, Immunologic
1
2020
21
0.040
Why?
Drug Synergism
1
2020
66
0.040
Why?
Antigens, Differentiation
1
2020
27
0.040
Why?
Hippocampus
2
1999
216
0.040
Why?
Pyridines
1
2020
79
0.040
Why?
Pyrazoles
1
2020
77
0.040
Why?
Protein Kinase Inhibitors
1
2020
90
0.040
Why?
Insulin-Like Growth Factor I
1
2020
84
0.040
Why?
Pyrimidines
1
2020
77
0.040
Why?
Drug Resistance, Neoplasm
1
2020
106
0.040
Why?
Area Under Curve
1
2020
90
0.040
Why?
Octamer Transcription Factor-3
1
2019
20
0.040
Why?
SOXB1 Transcription Factors
1
2019
18
0.040
Why?
Neoplasm Proteins
1
2020
146
0.040
Why?
Predictive Value of Tests
2
2012
880
0.040
Why?
HMGA2 Protein
1
2019
10
0.040
Why?
Astrocytes
1
2019
61
0.040
Why?
Down Syndrome
1
1999
15
0.040
Why?
MAP Kinase Signaling System
1
2019
64
0.040
Why?
Disease Susceptibility
1
2019
61
0.040
Why?
Rats
2
2014
1892
0.040
Why?
Limbic System
1
1998
15
0.040
Why?
Biometry
1
1998
14
0.040
Why?
Mediastinum
1
2018
14
0.030
Why?
Temporal Lobe
1
1998
33
0.030
Why?
Transcriptional Activation
1
2018
46
0.030
Why?
Down-Regulation
1
2018
131
0.030
Why?
Up-Regulation
1
2018
190
0.030
Why?
Feasibility Studies
1
2018
309
0.030
Why?
Biopsy
1
2018
249
0.030
Why?
Cell Movement
1
2018
165
0.030
Why?
Models, Biological
1
2019
403
0.030
Why?
Topotecan
1
2016
14
0.030
Why?
Observer Variation
2
2011
96
0.030
Why?
Dementia
1
1999
246
0.030
Why?
Stilbenes
1
2016
18
0.030
Why?
Cell Adhesion
1
2016
95
0.030
Why?
Disease Models, Animal
1
2019
1073
0.030
Why?
Receptors, CCR7
1
2015
4
0.030
Why?
Immunotherapy
1
2016
91
0.030
Why?
Vaccines, Subunit
1
2014
4
0.030
Why?
Poly I-C
1
2014
4
0.030
Why?
Cholinesterase Inhibitors
1
2015
37
0.030
Why?
Diagnosis, Differential
1
2016
502
0.030
Why?
Polylysine
1
2014
5
0.030
Why?
Blood-Brain Barrier
1
2015
52
0.030
Why?
Cancer Vaccines
1
2014
25
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
160
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
246
0.030
Why?
Longitudinal Studies
1
2016
760
0.030
Why?
Reoperation
1
2015
247
0.030
Why?
Learning
1
2015
84
0.030
Why?
Influenza A Virus, H3N2 Subtype
1
2014
21
0.030
Why?
Influenza B virus
1
2014
19
0.030
Why?
Vision, Low
1
2014
4
0.030
Why?
CD8-Positive T-Lymphocytes
1
2014
101
0.030
Why?
Pain
1
2015
303
0.020
Why?
Memory
1
2015
202
0.020
Why?
Retina
1
2014
83
0.020
Why?
Microsomes
1
2013
12
0.020
Why?
Endoplasmic Reticulum
1
2013
24
0.020
Why?
Genes, Dominant
1
2013
27
0.020
Why?
Hela Cells
1
2013
75
0.020
Why?
Inflammation
1
2016
500
0.020
Why?
Adenoviridae
1
2013
66
0.020
Why?
Spin Labels
1
2012
17
0.020
Why?
Karnofsky Performance Status
1
2012
12
0.020
Why?
Behavior, Animal
1
2014
299
0.020
Why?
Protein-Tyrosine Kinases
1
2012
36
0.020
Why?
Rats, Inbred F344
1
2012
150
0.020
Why?
Radiometry
1
2012
52
0.020
Why?
Motor Activity
1
2014
332
0.020
Why?
Drug Delivery Systems
1
2012
105
0.020
Why?
Otitis Media
1
2011
24
0.020
Why?
Pons
1
2010
7
0.020
Why?
Spinal Nerve Roots
1
2010
12
0.020
Why?
Sphingomyelin Phosphodiesterase
1
2010
4
0.020
Why?
Mutation
1
2013
497
0.020
Why?
Ceramides
1
2010
9
0.020
Why?
Fibroblast Growth Factor 2
1
2010
20
0.020
Why?
Angiotensin I
1
2012
237
0.020
Why?
Cell Death
1
2010
74
0.020
Why?
Enzyme Activation
1
2010
133
0.020
Why?
Medical Records
1
2010
75
0.020
Why?
Sensitivity and Specificity
1
2011
555
0.020
Why?
Chi-Square Distribution
1
2010
287
0.020
Why?
Vascular Endothelial Growth Factor A
1
2010
113
0.020
Why?
Cell Survival
1
2010
286
0.020
Why?
Bone Marrow Transplantation
1
2009
66
0.020
Why?
Reproducibility of Results
1
2011
755
0.020
Why?
Antibodies, Monoclonal
1
2010
246
0.020
Why?
Apoptosis
1
2010
367
0.020
Why?
Miniaturization
1
2007
5
0.020
Why?
Computer Systems
1
2007
15
0.020
Why?
Equipment Failure Analysis
1
2007
43
0.020
Why?
Myositis
1
2006
10
0.020
Why?
Staining and Labeling
1
2007
62
0.020
Why?
Equipment Design
1
2007
177
0.020
Why?
Atrophy
1
1999
46
0.010
Why?
Entorhinal Cortex
1
1998
1
0.010
Why?
Anatomy, Cross-Sectional
1
1998
19
0.010
Why?
Comorbidity
1
1999
563
0.010
Why?
Cross-Sectional Studies
1
1999
1485
0.010
Why?
Chan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (363)
Explore
_
Co-Authors (51)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_